普優生技股份有限公司
Update:2025/12/03
Industries
Main Industry
Health Care
Main Product/Service
1. CTC Detection System
2. NK Cell Expansion Kit
3. MSC Expansion Kit
4. Anti-EpCAM Monoclonal Antibody
5. EPCAM-FITC
2. NK Cell Expansion Kit
3. MSC Expansion Kit
4. Anti-EpCAM Monoclonal Antibody
5. EPCAM-FITC
Founded Year
2017
Unified Business No.
55734941
Status
Active
Number of Employees
0
Total Paid-in
Capital
39,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
BioMab, Inc. is an immune-based precision medicine company based in Taiwan. Spun-out of Academia Sinica, our current product portfolio focuses on two primary areas of precision medicine: circulating tumor cell (CTC) and cell therapy.